Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.

Baltch AL, Lawrence D, Ritz WJ, Andersen N, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.

Chemotherapy. 2012;58(2):146-51. doi: 10.1159/000337076. Epub 2012 May 12.

PMID:
22584412
2.

Effects of echinocandins on cytokine/chemokine production by human monocytes activated by infection with Candida glabrata or by lipopolysaccharide.

Baltch AL, Lawrence DA, Ritz WJ, Andersen NJ, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.

Diagn Microbiol Infect Dis. 2012 Mar;72(3):226-33. doi: 10.1016/j.diagmicrobio.2011.11.004. Epub 2011 Dec 29.

PMID:
22209510
3.

Comparison of CLSI broth macrodilution and microdilution methods for echinocandin susceptibility testing of 5 Candida species.

Bopp LH, Baltch AL, Ritz WJ, Smith RP.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):320-2. doi: 10.1016/j.diagmicrobio.2011.08.001. Epub 2011 Sep 19.

PMID:
21937187
4.

Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis.

Smith RP, Baltch A, Bopp LH, Ritz WJ, Michelsen PP.

Diagn Microbiol Infect Dis. 2011 Oct;71(2):131-8. doi: 10.1016/j.diagmicrobio.2011.06.018. Epub 2011 Aug 23.

PMID:
21865002
5.

Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.

Bopp LH, Baltch AL, Ritz WJ, Michelsen PB, Smith RP.

Diagn Microbiol Infect Dis. 2011 Jan;69(1):86-93. doi: 10.1016/j.diagmicrobio.2010.08.023.

PMID:
21146719
6.

IFN-gamma enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics.

Smith RP, Baltch AL, Ritz WJ, Michelsen PB, Bopp LH.

Cytokine. 2010 Sep;51(3):274-7. doi: 10.1016/j.cyto.2010.06.004. Epub 2010 Jun 30.

PMID:
20580568
7.
8.
9.

Effect of recombinant human activated protein C on the bactericidal activity of human monocytes and modulation of pro-inflammatory cytokines in the presence of antimicrobial agents.

Baltch AL, Bopp LH, Ritz WJ, Michelsen PB, Yan SB, Um S, Smith RP.

J Antimicrob Chemother. 2007 Jun;59(6):1177-81. Epub 2007 Apr 11.

PMID:
17428810
11.

Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.

Bopp LH, Baltch AL, Ritz WJ, Michelsen PB, Smith RP.

J Med Microbiol. 2006 Jul;55(Pt 7):865-70.

PMID:
16772413
12.
13.
14.

Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.

Baltch AL, Smith RP, Ritz WJ, Carpenter AN, Bopp LH, Michelsen PB, Carlyn CJ, Hibbs JR.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):205-12.

PMID:
15541607
15.

In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.

Smith RP, Baltch AL, Ritz WJ, Carpenter AN, Halse TA, Bopp LH.

Antimicrob Agents Chemother. 2004 Jun;48(6):2081-4.

16.

Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.

Baltch AL, Smith RP, Ritz WJ, Carpenter-Knaggs A, Michelsen PB, Carlyn CJ, Bopp LH, Hibbs JR.

Chemotherapy. 2003 May;49(1-2):27-32.

PMID:
12714806
17.

Use of the microbial growth curve in postantibiotic effect studies of Legionella pneumophila.

Smith RP, Baltch AL, Michelsen PB, Ritz WJ, Alteri R.

Antimicrob Agents Chemother. 2003 Mar;47(3):1081-7.

19.

Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.

Baltch AL, Smith RP, Franke MA, Ritz WJ, Michelsen PB, Bopp LH.

Antimicrob Agents Chemother. 2001 Jan;45(1):96-104.

20.

Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.

Baltch AL, Smith RP, Ritz WJ, Franke MA, Michelsen PB.

J Antimicrob Chemother. 2000 Jul;46(1):51-5.

PMID:
10882688
21.

Microbicidal activity of MDI-P against Candida albicans, Staphylococcus aureus, Pseudomonas aeruginosa, and Legionella pneumophila.

Baltch AL, Smith RP, Franke MA, Ritz WJ, Michelsen P, Bopp LH, Singh JK.

Am J Infect Control. 2000 Jun;28(3):251-7. Review.

PMID:
10840346
22.

Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State.

Bopp LH, Schoonmaker DJ, Baltch AL, Smith RP, Ritz WJ.

Am J Infect Control. 1999 Oct;27(5):411-7.

PMID:
10511488
24.

Effect of pentoxifylline on the course of systemic Candida albicans infection in mice.

Louie A, Baltch AL, Franke MA, Ritz WJ, Smith RP, Singh JK, Gordon MA.

J Antimicrob Chemother. 1996 May;37(5):943-54.

PMID:
8737144
25.
26.

Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis.

Louie A, Baltch AL, Smith RP, Franke MA, Ritz WJ, Singh JK, Gordon MA.

Infect Immun. 1994 Jul;62(7):2761-72.

27.

Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenem.

Cooper GL, Louie A, Baltch AL, Chu RC, Smith RP, Ritz WJ, Michelsen P.

J Clin Microbiol. 1993 Sep;31(9):2366-70.

30.

In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.

Louie A, Baltch AL, Ritz WJ, Smith RP.

Chemotherapy. 1991;37(4):275-82.

PMID:
1665123
31.

In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.

Valdes JM, Baltch AL, Smith RP, Ritz WJ.

J Antimicrob Chemother. 1990 Dec;26(6):855-7. No abstract available.

PMID:
2081726
32.

Comparative therapy with cefpirome alone and in combination with rifampin and/or gentamicin against a disseminated Pseudomonas aeruginosa infection in leukopenic mice.

Valdes JM, Baltch AL, Smith RP, Franke M, Ritz WJ, Williams S, Michelsen P, Singh J.

J Infect Dis. 1990 Nov;162(5):1112-7.

PMID:
2121835
33.

The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.

Valdes JM, Baltch AL, Smith RP, Hammer MC, Ritz WJ.

J Antimicrob Chemother. 1990 Apr;25(4):575-84.

PMID:
2112539
34.

Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus.

Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PH.

J Infect Dis. 1990 Jan;161(1):45-51.

PMID:
2295858

Supplemental Content

Support Center